Skip to main content


Featured Article
Researchers recently compared how the use of lipophilic or hydrophilic statins impacted hepatocellular carcinoma in patients with viral hepatitis.
A recent study investigated whether drug manufacturers saw increased net revenue after reduced list prices for hepatitis C treatments and changes to discounts provided under the 340B program.

Interactive Features

Does hepatitis C treatment success improve insulin resistance in patients with diabetes?
Back to Top